Chemometec A/S Current Assets
The Current Assets of Chemometec A/S (CHEMM.CO) as of Oct 26, 2026 is 425.61 M DKK. In the previous year, Current Assets was 549.47 M DKK — a change of -22.54% (lower).
Get this data via API
Financial Data API
Current Assets
425.61 MDKK
YoY
-22.54%
Last updated:
The Chemometec A/S Current Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Current Assets | YoY |
|---|---|---|
| 425.61 MDKK | -22.54% | |
| 549.47 MDKK | +12.18% | |
| 489.80 MDKK | -0.58% | |
| 492.66 MDKK | +38.15% | |
| 356.60 MDKK | +45.94% | |
| 244.36 MDKK | +46.14% | |
| 167.20 MDKK | +7.99% | |
| 154.83 MDKK | +233.71% | |
| 46.40 MDKK | +13.11% | |
| 41.02 MDKK | +6.40% | |
| 38.55 MDKK | +14.64% | |
| 33.63 MDKK | +40.37% | |
| 23.96 MDKK | +4.41% | |
| 22.95 MDKK | +5.10% | |
| 21.83 MDKK | +8.64% | |
| 20.10 MDKK | -14.65% | |
| 23.55 MDKK | -13.39% | |
| 27.19 MDKK | -13.00% | |
| 31.25 MDKK | -23.19% | |
| 40.68 MDKK | +58.24% | |
| 25.71 MDKK | +416.00% | |
| 4.98 MDKK | +396.22% | |
| 1.00 MDKK | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Chemometec A/S Stock analysis
Frequently Asked Questions about Chemometec A/S stock
Current Assets of Chemometec A/S is 425.61 M DKK in 2026.
Current Assets of Chemometec A/S changed from 549.47 M DKK to 425.61 M DKK, representing a -22.54% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Assets Chemometec A/S since 2006 – with annual values, charts, and detailed analysis.
Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.
Current Assets's DKK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Chemometec A/S historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Balance Sheet — Chemometec A/S
All Key Metrics — Chemometec A/S
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth